Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes
- PMID: 10523462
- DOI: 10.1016/s0095-4543(05)70133-0
Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes
Abstract
According to several prospective population-based studies, glycemic control influences the risk for cardiovascular disease, including coronary heart disease, independently of conventional risk factors in patients with type 2 diabetes. Recent clinical trials, particularly the United Kingdom Prospective Diabetes Study, have shown that microvascular complications and macrovascular complications, although to a lesser extent, can be prevented in patients with type 2 diabetes with correction of glycemic control. However, in the treatment and prevention of cardiovascular disease in type 2 diabetes, all known cardiovascular risk factors should be attacked simultaneously.
Similar articles
-
Hyperglycemia and cardiovascular disease in type 2 diabetes.Diabetes. 1999 May;48(5):937-42. doi: 10.2337/diabetes.48.5.937. Diabetes. 1999. PMID: 10331395 Review.
-
Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.Diabetes Care. 1999 Apr;22 Suppl 3:C54-6. Diabetes Care. 1999. PMID: 10189563 Review.
-
Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.Clin Ther. 2011 Jun;33(6):665-78. doi: 10.1016/j.clinthera.2011.04.025. Clin Ther. 2011. PMID: 21704233 Review.
-
Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.Horm Metab Res. 2007 Sep;39(9):683-6. doi: 10.1055/s-2007-985157. Horm Metab Res. 2007. PMID: 17846977 Review.
-
[Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].Lakartidningen. 2001 Feb 28;98(9):937-40. Lakartidningen. 2001. PMID: 11292972 Review. Swedish.
Cited by
-
In vivo and in vitro evidence of the sex-dependent pharmacokinetics and disposition of G004, a potential hypoglycemic agent, in rats.Eur J Drug Metab Pharmacokinet. 2015 Jun;40(2):187-202. doi: 10.1007/s13318-014-0196-7. Epub 2014 Apr 3. Eur J Drug Metab Pharmacokinet. 2015. PMID: 24696324
-
Reactive oxygen species mediate a cellular 'memory' of high glucose stress signalling.Diabetologia. 2007 Jul;50(7):1523-31. doi: 10.1007/s00125-007-0684-2. Epub 2007 May 17. Diabetologia. 2007. PMID: 17508197
-
Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.Naunyn Schmiedebergs Arch Pharmacol. 2017 Apr;390(4):397-408. doi: 10.1007/s00210-016-1336-1. Epub 2017 Jan 10. Naunyn Schmiedebergs Arch Pharmacol. 2017. PMID: 28074232
-
Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.In Vitro Cell Dev Biol Anim. 2007 Sep-Oct;43(8-9):297-305. doi: 10.1007/s11626-007-9052-2. Epub 2007 Sep 12. In Vitro Cell Dev Biol Anim. 2007. PMID: 17849168
-
Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.Br J Pharmacol. 2009 Mar;156(5):713-27. doi: 10.1111/j.1476-5381.2008.00086.x. Epub 2009 Feb 6. Br J Pharmacol. 2009. PMID: 19210748 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical